Penicillin g benzathine
Bicillin (penicillin g benzathine) is a small molecule pharmaceutical. Penicillin g benzathine was first approved as Permapen on 1982-01-01. It is used to treat actinomycosis, anthrax, bacterial infections, bacterial skin diseases, and botulism amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Bicillin l-a (discontinued: Bicillin, Bicillin l-a, Permapen)
CombinationsBicillin c-r (discontinued: Bicillin c-r)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Penicillin g benzathine
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| BICILLIN L-A | King Pharmaceuticals | N-050141 RX | 1982-01-01 | 1 products, RLD, RS |
Show 5 discontinued
Penicillin g benzathine
+
Penicillin g procaine
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| BICILLIN C-R | King Pharmaceuticals | N-050138 RX | 1982-01-01 | 1 products, RLD, RS |
| BICILLIN C-R 900/300 | King Pharmaceuticals | N-050138 RX | 1982-01-01 | 1 products, RLD, RS |
Show 1 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| bicillin c-r 900/300 | New Drug Application | 2024-06-03 |
| bicillin cr | New Drug Application | 2024-06-04 |
| bicillin l-a | New Drug Application | 2024-07-12 |
| extencilline | unapproved drug for use in drug shortage | 2024-07-18 |
| lentocilin | unapproved drug for use in drug shortage | 2024-06-07 |
| neolinn | OTC monograph not final | 2021-06-02 |
Indications
FDA
EMA
Show 15 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
Clinical
Clinical Trials
840 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infections | D007239 | EFO_0000544 | — | 12 | 22 | 51 | 121 | 69 | 260 |
| Communicable diseases | D003141 | — | — | 1 | 6 | 25 | 43 | 28 | 100 |
| Helicobacter infections | D016481 | EFO_1000961 | — | 5 | 8 | 19 | 39 | 24 | 91 |
| Pneumonia | D011014 | EFO_0003106 | J18 | 4 | 11 | 23 | 21 | 20 | 71 |
| Gastritis | D005756 | EFO_0000217 | K29.7 | 3 | 2 | 7 | 17 | 4 | 32 |
| Healthy volunteers/patients | — | — | — | 17 | — | 1 | 3 | 7 | 28 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | 2 | 3 | 6 | 8 | 11 | 28 |
| Periodontitis | D010518 | EFO_0000649 | K05.3 | 1 | 5 | 6 | 10 | 7 | 26 |
| Sinusitis | D012852 | EFO_0007486 | J32 | — | 1 | 5 | 11 | 6 | 23 |
| Bacterial infections | D001424 | — | A49 | 4 | 2 | 1 | 9 | 6 | 22 |
Show 171 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | — | 5 | 5 | — | 4 | 12 |
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | 1 | 6 | 2 | — | 1 | 9 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | 2 | 4 | — | 3 | 7 |
| Abscess | D000038 | EFO_0003030 | — | — | 1 | 4 | — | 2 | 7 |
| Leukemia | D007938 | — | C95 | — | 2 | 3 | — | 2 | 5 |
| Hematologic neoplasms | D019337 | — | — | — | 2 | 2 | — | 2 | 5 |
| Multiple myeloma | D009101 | — | C90.0 | — | 2 | 3 | — | 2 | 5 |
| Rheumatic heart disease | D012214 | EFO_1001161 | I09.9 | — | 2 | 1 | — | 2 | 5 |
| Covid-19 | D000086382 | — | U07.1 | — | 1 | 2 | — | 1 | 4 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | 1 | 1 | — | 2 | 4 |
Show 74 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | 1 | — | — | 3 | 4 |
| Pulmonary tuberculosis | D014397 | EFO_1000049 | A15 | — | 4 | — | — | — | 4 |
| B-cell lymphoma marginal zone | D018442 | — | C88.4 | — | 1 | — | — | 2 | 3 |
| Congenital syphilis | D013590 | EFO_0007219 | A50 | — | 2 | — | — | 1 | 3 |
| Gastrointestinal microbiome | D000069196 | — | — | — | 1 | — | — | 1 | 2 |
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | — | 1 | — | — | 1 | 2 |
| Systemic inflammatory response syndrome | D018746 | EFO_1001478 | R65.10 | — | 1 | — | — | 1 | 2 |
| Psoriasis | D011565 | EFO_0000676 | L40 | — | 1 | — | — | 1 | 2 |
| Cleft palate | D002972 | EFO_0003920 | Q35 | — | 1 | — | — | 1 | 2 |
| B-cell lymphoma | D016393 | — | — | — | 1 | — | — | 1 | 2 |
Show 27 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pharmacokinetics | D010599 | — | — | 1 | — | — | — | 2 | 3 |
| Gastrointestinal diseases | D005767 | — | — | 1 | — | — | — | 2 | 3 |
| Digestive system diseases | D004066 | EFO_0000405 | K92.9 | 1 | — | — | — | 2 | 3 |
| Chemical and drug induced liver injury | D056486 | EFO_0004228 | — | 1 | — | — | — | 1 | 2 |
| Impacted tooth | D014095 | — | K01.1 | 1 | — | — | — | 1 | 2 |
| Anxiety | D001007 | EFO_0005230 | F41.1 | 1 | — | — | — | 1 | 2 |
| Drug interactions | D004347 | — | — | 2 | — | — | — | — | 2 |
| Respiratory tract diseases | D012140 | — | — | 2 | — | — | — | — | 2 |
| Respiration disorders | D012120 | — | J00-J99 | 2 | — | — | — | — | 2 |
| Non-muscle invasive bladder neoplasms | D000093284 | — | — | 2 | — | — | — | — | 2 |
Show 16 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Kwashiorkor | D007732 | EFO_1001009 | E40 | — | — | — | — | 4 | 4 |
| Hematopoietic stem cell transplantation | D018380 | — | — | — | — | — | — | 2 | 2 |
| Seizures | D012640 | — | G40.4 | — | — | — | — | 2 | 2 |
| Gram-positive bacterial infections | D016908 | — | — | — | — | — | — | 2 | 2 |
| Protein-energy malnutrition | D011502 | EFO_0009563 | E41 | — | — | — | — | 2 | 2 |
| Thyroid nodule | D016606 | EFO_1001436 | — | — | — | — | — | 2 | 2 |
| Periapical periodontitis | D010485 | EFO_1001391 | K04.5 | — | — | — | — | 2 | 2 |
| Gingival recession | D005889 | — | K06.0 | — | — | — | — | 2 | 2 |
| Cytokine release syndrome | D000080424 | — | D89.83 | — | — | — | — | 1 | 1 |
| Viral pneumonia | D011024 | EFO_0007541 | J12.9 | — | — | — | — | 1 | 1 |
Show 106 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Penicillin g benzathine |
| INN | — |
| Description | Benzathine benzylpenicillin, also known as benzathine penicillin G, is an antibiotic medication useful for the treatment of a number of bacterial infections. Specifically it is used to treat strep throat, diphtheria, syphilis, and yaws. It is also used to prevent rheumatic fever. It is given by injection into a muscle.
|
| Classification | Small molecule |
| Drug class | penicillins |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.O.O.O.O.c1ccc(CNCCNCc2ccccc2)cc1 |
Identifiers
| PDB | — |
| CAS-ID | 1538-09-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3989515 |
| ChEBI ID | — |
| PubChem CID | 15232 |
| DrugBank | DB09323 |
| UNII ID | — |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Bicillin – Pfizer
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
Penicillin g benzathine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 4,849 documents
View more details
Safety
Black-box Warning
Black-box warning for: Bicillin c-r 900/300, Bicillin cr, Bicillin l-a
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,184 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use